Back

Do beta-blockers increase the risk for hospitalizations in heart failure with preserved ejection fraction? a secondary analysis of beta-blocker use in the TOPCAT trial

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Treatment of heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Daniel Silverman

Medical University of South Carolina, Charleston (United States of America)

8 More presentations in this session

Presentation thumbnail
Professor D. Logeart (Paris, FR)
Abstract
Presentation thumbnail
Doctor M. Trindade (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Doctor S. Scalvini (Lumezzane, IT)
Abstract Slides
Presentation thumbnail
Doctor N. Pavo (Vienna, AT)
Abstract
Presentation thumbnail
Doctor Y. Illahi (Multan, PK)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Treatment of heart failure

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources